BEAM
Beam Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
USD29.55
+0.59 (+2.04%)
Rating:C
Company Profile
CEO
John Evans
IPO Date
2020-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$28.71
Prev. Close
$28.96
Day Low
$28.30
Day High
$29.65
52W Low
$15.60
52W High
$36.44
Market Cap
$3.04B
Volume
1.15M